Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Talpaz

Showing results (301-310 of 350) with videos related to

Pageof 35
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 1998
Selective inhibition of cell proliferation and BCR-ABL phosphorylation in acute lymphoblastic leukemia cells expressing Mr 190,000 BCR-ABL protein by a tyrosine kinase inhibitor (CGP-57148)M Beran, X Cao, Z Estrov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2000
Caspase 2 and caspase 3 as predictors of complete remission and survival in adults with acute lymphoblastic leukemiaS Faderl, P F Thall, H M Kantarjian, et al.
Stem Cells (Dayton, Ohio)|October 1, 1993
Molecular approaches to the diagnosis and treatment of cancerA B Deisseroth, H Kantarjian, M Talpaz, et al.
Cancer Research|June 26, 1999
Autocrine interleukin-1beta production in leukemia: evidence for the involvement of mutated RASD M Beaupre, M Talpaz, F C Marini, et al.
Cancer|September 15, 1991
Intensive chemotherapy induction followed by interferon-alpha maintenance in patients with Philadelphia chromosome-positive chronic myelogenous leukemiaH M Kantarjian, M Talpaz, M J Keating, et al.
Leukemia|February 26, 2011
p53 stabilization induces apoptosis in chronic myeloid leukemia blast crisis cellsL F Peterson, E Mitrikeska, D Giannola, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 6, 1999
Analysis of Philadelphia chromosome-negative BCR-ABL-positive chronic myelogenous leukemia by hypermetaphase fluorescence in situ hybridizationD Seong, H M Kantarjian, M Albitar, et al.
British Journal of Haematology|July 1, 1991
Differential dose-related haematological effects of GM-CSF in pancytopenia: evidence supporting the advantage of low- over high-dose administration in selected patientsR Kurzrock, M Talpaz, J A Gomez, et al.
Blood|July 1, 1989
Fludarabine: a new agent with major activity against chronic lymphocytic leukemiaM J Keating, H Kantarjian, M Talpaz, et al.
British Journal of Haematology|March 1, 1991
Effects of low doses of recombinant human granulocyte-macrophage colony stimulating factor (GM-CSF) in patients with myelodysplastic syndromesE H Estey, R Kurzrock, M Talpaz, et al.
Pageof 35

Showing results (301-310 of 350) with videos related to

Sort By:
Pageof 35
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 1998
Selective inhibition of cell proliferation and BCR-ABL phosphorylation in acute lymphoblastic leukemia cells expressing Mr 190,000 BCR-ABL protein by a tyrosine kinase inhibitor (CGP-57148)M Beran, X Cao, Z Estrov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2000
Caspase 2 and caspase 3 as predictors of complete remission and survival in adults with acute lymphoblastic leukemiaS Faderl, P F Thall, H M Kantarjian, et al.
Stem Cells (Dayton, Ohio)|October 1, 1993
Molecular approaches to the diagnosis and treatment of cancerA B Deisseroth, H Kantarjian, M Talpaz, et al.
Cancer Research|June 26, 1999
Autocrine interleukin-1beta production in leukemia: evidence for the involvement of mutated RASD M Beaupre, M Talpaz, F C Marini, et al.
Cancer|September 15, 1991
Intensive chemotherapy induction followed by interferon-alpha maintenance in patients with Philadelphia chromosome-positive chronic myelogenous leukemiaH M Kantarjian, M Talpaz, M J Keating, et al.
Leukemia|February 26, 2011
p53 stabilization induces apoptosis in chronic myeloid leukemia blast crisis cellsL F Peterson, E Mitrikeska, D Giannola, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 6, 1999
Analysis of Philadelphia chromosome-negative BCR-ABL-positive chronic myelogenous leukemia by hypermetaphase fluorescence in situ hybridizationD Seong, H M Kantarjian, M Albitar, et al.
British Journal of Haematology|July 1, 1991
Differential dose-related haematological effects of GM-CSF in pancytopenia: evidence supporting the advantage of low- over high-dose administration in selected patientsR Kurzrock, M Talpaz, J A Gomez, et al.
Blood|July 1, 1989
Fludarabine: a new agent with major activity against chronic lymphocytic leukemiaM J Keating, H Kantarjian, M Talpaz, et al.
British Journal of Haematology|March 1, 1991
Effects of low doses of recombinant human granulocyte-macrophage colony stimulating factor (GM-CSF) in patients with myelodysplastic syndromesE H Estey, R Kurzrock, M Talpaz, et al.
Pageof 35